世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000039080

大腸がん治療薬の世界市場(2024-2028)

TechNavio

Global colorectal cancer therapeutics market 2024-2028

発刊日 2024/06/12

言語英語

体裁PDF/146ページ

ライセンス/価格146ページ

0000039080

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

大腸がん治療薬市場は2023年から2028年に20億180万米ドル、予測期間中のCAGRは4.5%で成長すると予測されます。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。高齢者人口の増加、大腸がんの発生率の上昇、併用療法の導入などが市場を牽引しています。

調査範囲

  • 市場セグメント
    ➣ タイプ別
      ◇ 標的療法
      ◇ 免疫療法
      ◇ 化学療法
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ 世界のその他の地域

この調査では、低分子キナーゼ阻害薬の開発が今後数年間の大腸がん治療法市場成長を牽引する主要因の1つであるとしています。また、遺伝子治療や個別化治療法の出現は、市場の大きな需要につながります。

大腸がん治療薬市場に関するレポートは、次の分野をカバーしています。

  • 大腸がん治療薬市場の規模
  • 大腸がん治療薬市場の予測
  • 大腸がん治療薬市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。

  • 調査企業
    ➣ Accord Healthcare Ltd.
    ➣ Amgen Inc.
    ➣ Amneal Pharmaceuticals Inc.
    ➣ Bayer AG, Biocon Ltd.
    ➣ Bristol Myers Squibb Co.
    ➣ CK Hutchison Holdings Ltd.
    ➣ Eli Lilly and Co.
    ➣ F. Hoffmann La Roche Ltd.
    ➣ Fresenius SE and Co. KGaA
    ➣ Hetero Drugs Ltd.
    ➣ Hikma Pharmaceuticals PLC
    ➣ Merck and Co. Inc.
    ➣ 小野製薬工業(Ono Pharmaceutical Co. Ltd.)
    ➣ 大塚ホールディングス(Otsuka Holdings Co. Ltd.)
    ➣ Pfizer Inc.
    ➣ Sanofi SA
    ➣ Sun Pharmaceutical Industries Ltd.
    ➣ Teva Pharmaceutical Industries Ltd.
    ➣ Viatris Inc.

また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global Colorectal Cancer Therapeutics Market 2018 - 2022
Historic Market Size - Data Table on Global Colorectal Cancer Therapeutics Market 2018 - 2022 ($ million)
4.2 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type
6.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
6.3 Targeted therapy - Market size and forecast 2023-2028
Chart on Targeted therapy - Market size and forecast 2023-2028 ($ million)
Data Table on Targeted therapy - Market size and forecast 2023-2028 ($ million)
Chart on Targeted therapy - Year-over-year growth 2023-2028 (%)
Data Table on Targeted therapy - Year-over-year growth 2023-2028 (%)
6.4 Immunotherapy - Market size and forecast 2023-2028
Chart on Immunotherapy - Market size and forecast 2023-2028 ($ million)
Data Table on Immunotherapy - Market size and forecast 2023-2028 ($ million)
Chart on Immunotherapy - Year-over-year growth 2023-2028 (%)
Data Table on Immunotherapy - Year-over-year growth 2023-2028 (%)
6.5 Chemotherapy - Market size and forecast 2023-2028
Chart on Chemotherapy - Market size and forecast 2023-2028 ($ million)
Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ million)
Chart on Chemotherapy - Year-over-year growth 2023-2028 (%)
Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)

7 Customer Landscape
7.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape
8.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
8.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.9 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
8.10 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
8.11 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)

9 Drivers, Challenges, and Opportunity/Restraints
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints

10 Competitive Landscape
10.1 Overview
10.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
Overview on factors of disruption
10.4 Industry risks
Impact of key risks on business

11 Competitive Analysis
11.1 Companies profiled
Companies covered
11.2 Market positioning of companies
Matrix on companies position and classification
11.3 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key news
Amgen Inc. - Key offerings
11.4 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
11.5 Biocon Ltd.
Biocon Ltd. - Overview
Biocon Ltd. - Business segments
Biocon Ltd. - Key offerings
Biocon Ltd. - Segment focus
11.6 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
11.7 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key news
Eli Lilly and Co. - Key offerings
11.8 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
11.9 Fresenius SE and Co. KGaA
Fresenius SE and Co. KGaA - Overview
Fresenius SE and Co. KGaA - Business segments
Fresenius SE and Co. KGaA - Key news
Fresenius SE and Co. KGaA - Key offerings
Fresenius SE and Co. KGaA - Segment focus
11.10 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
11.11 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
11.12 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus

12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
12.3 Currency conversion rates for US$
Currency conversion rates for US$
12.4 Research methodology
Research methodology
12.5 Data procurement
Information sources
12.6 Data validation
Data validation
12.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
12.8 Data synthesis
Data synthesis
12.9 360 degree market analysis
360 degree market analysis
12.10 List of abbreviations
List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Company Market Positioning
Exhibits9: Parent Market
Exhibits10: Data Table on - Parent Market
Exhibits11: Market characteristics analysis
Exhibits12: Value Chain Analysis
Exhibits13: Offerings of companies included in the market definition
Exhibits14: Market segments
Exhibits15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Historic Market Size - Data Table on Global Colorectal Cancer Therapeutics Market 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Type - Market share 2023-2028 (%)
Exhibits31: Data Table on Type - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Targeted therapy - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Targeted therapy - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Targeted therapy - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Targeted therapy - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Immunotherapy - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Immunotherapy - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Immunotherapy - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Immunotherapy - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Chemotherapy - Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on Chemotherapy - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Type ($ million)
Exhibits47: Data Table on Market opportunity by Type ($ million)
Exhibits48: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits49: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits50: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits51: Chart on Geographic comparison
Exhibits52: Data Table on Geographic comparison
Exhibits53: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits54: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits55: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits56: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits57: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits58: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits59: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits60: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits61: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits62: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits63: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits64: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits65: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits66: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits67: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits68: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits69: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits89: Market opportunity By Geographical Landscape ($ million)
Exhibits90: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits91: Impact of drivers and challenges in 2023 and 2028
Exhibits92: Overview on criticality of inputs and factors of differentiation
Exhibits93: Overview on factors of disruption
Exhibits94: Impact of key risks on business
Exhibits95: Companies covered
Exhibits96: Matrix on companies position and classification
Exhibits97: Amgen Inc. - Overview
Exhibits98: Amgen Inc. - Product / Service
Exhibits99: Amgen Inc. - Key news
Exhibits100: Amgen Inc. - Key offerings
Exhibits101: Bayer AG - Overview
Exhibits102: Bayer AG - Business segments
Exhibits103: Bayer AG - Key news
Exhibits104: Bayer AG - Key offerings
Exhibits105: Bayer AG - Segment focus
Exhibits106: Biocon Ltd. - Overview
Exhibits107: Biocon Ltd. - Business segments
Exhibits108: Biocon Ltd. - Key offerings
Exhibits109: Biocon Ltd. - Segment focus
Exhibits110: Bristol Myers Squibb Co. - Overview
Exhibits111: Bristol Myers Squibb Co. - Product / Service
Exhibits112: Bristol Myers Squibb Co. - Key news
Exhibits113: Bristol Myers Squibb Co. - Key offerings
Exhibits114: Eli Lilly and Co. - Overview
Exhibits115: Eli Lilly and Co. - Product / Service
Exhibits116: Eli Lilly and Co. - Key news
Exhibits117: Eli Lilly and Co. - Key offerings
Exhibits118: F. Hoffmann La Roche Ltd. - Overview
Exhibits119: F. Hoffmann La Roche Ltd. - Business segments
Exhibits120: F. Hoffmann La Roche Ltd. - Key news
Exhibits121: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits122: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits123: Fresenius SE and Co. KGaA - Overview
Exhibits124: Fresenius SE and Co. KGaA - Business segments
Exhibits125: Fresenius SE and Co. KGaA - Key news
Exhibits126: Fresenius SE and Co. KGaA - Key offerings
Exhibits127: Fresenius SE and Co. KGaA - Segment focus
Exhibits128: Merck and Co. Inc. - Overview
Exhibits129: Merck and Co. Inc. - Business segments
Exhibits130: Merck and Co. Inc. - Key news
Exhibits131: Merck and Co. Inc. - Key offerings
Exhibits132: Merck and Co. Inc. - Segment focus
Exhibits133: Sanofi SA - Overview
Exhibits134: Sanofi SA - Business segments
Exhibits135: Sanofi SA - Key news
Exhibits136: Sanofi SA - Key offerings
Exhibits137: Sanofi SA - Segment focus
Exhibits138: Viatris Inc. - Overview
Exhibits139: Viatris Inc. - Business segments
Exhibits140: Viatris Inc. - Key news
Exhibits141: Viatris Inc. - Key offerings
Exhibits142: Viatris Inc. - Segment focus
Exhibits143: Inclusions checklist
Exhibits144: Exclusions checklist
Exhibits145: Currency conversion rates for US$
Exhibits146: Research methodology
Exhibits147: Information sources
Exhibits148: Data validation
Exhibits149: Validation techniques employed for market sizing
Exhibits150: Data synthesis
Exhibits151: 360 degree market analysis
Exhibits152: List of abbreviations

この商品のレポートナンバー

0000039080

TOP